• Evaluation of in-vitro and in-vivo regulatory (eco-)toxicological bioassays and agro-chemical field trials.
  • Design and analysis of dose-response studies in phase IIb clinical trials, exposure epidemiology, etc.
  • (Bio)equivalence considering multiple, different-scaled endpoints in nutritional safety studies, randomized clinical trials (incl. non-inferiority) and eco-toxicology.
  • Complex R-software
  • And more…. Based on >30 years experience in cooperation with international companies, CRO’s , governmental agencies and regulatory bodies.